
99.67%
Purity
Passed full QC panel
- Variant
- IGF-1 LR3 1mg
- Lot
- I0101
- Net Peptide Content
- 1.51 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics
Valence Labs Research
IGF Receptor Research Peptide
IGF-1 LR3, also described as Long R3 IGF-I, is an analogue of insulin-like growth factor I studied in IGF receptor signaling research.
Relative to native IGF-I, Long R3 IGF-I is examined for reduced interaction with IGF-binding proteins, supporting research on IGF/IGFBP relationships and cellular IGF signaling.
IGF-1 LR3 is studied as an IGF-I analogue in research involving IGF receptor pathways.
Research interest includes reduced interaction or affinity with IGF-binding proteins relative to native IGF-I.
Experimental work has used Long R3 IGF-I to examine cellular IGF signaling in laboratory models.
Research involving Long R3 IGF-I includes experimental and comparative models. Findings from those models should not be interpreted as established human treatment outcomes.
This page summarizes published research contexts and does not provide administration, dosing, or performance-related guidance.
Catalog details for this product.

99.67%
Purity
Passed full QC panel
IGF-1 LR3
1mg

Please confirm you are 21 years of age or older to enter.
By entering, you confirm that you meet our minimum age requirement.